BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2024 5:32:19 AM | Browse: 66 | Download: 192
 |
Received |
|
2024-08-01 06:43 |
 |
Peer-Review Started |
|
2024-08-01 06:43 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-08-10 20:11 |
 |
Revised |
|
2024-08-11 11:36 |
 |
Second Decision |
|
2024-08-22 02:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-08-22 07:13 |
 |
Articles in Press |
|
2024-08-22 07:13 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-08-23 01:16 |
 |
Publish the Manuscript Online |
|
2024-08-26 05:32 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Letter to the Editor |
Article Title |
Potential plausible role of Wharton’s jelly mesenchymal stem cells for diabetic bone regeneration
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Sheng Zheng, Guan-Yu Hu, Jun-Hua Li and Yi-Kai Li |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
China Postdoctoral Science Foundation |
2024M751344 |
Postdoctoral Fellowship Program of China Postdoctoral Science Foundation |
GZC20231088 |
|
Corresponding Author |
Yi-Kai Li, MD, PhD, Chief Physician, Full Professor, Research Scientist, Department of Traditional Chinese Orthopedics and Traumatology, The Third Affiliated Hospital of Southern Medical University, No. 183 Zhongshan Avenue West, Tianhe District, Guangzhou 510630, Guangdong Province, China. ortho@smu.edu.cn |
Key Words |
Wharton’s jelly mesenchymal stem cells; Vascular endothelial growth factor; Osteogenesis; Angiogenesis; Diabetic bone regeneration |
Core Tip |
Both osteogenesis and angiogenesis are closely related to bone regeneration. Diabetes mellitus normally impairs angiogenesis, which leads to diabetic bone regeneration deficiency. Wharton’s jelly mesenchymal stem cells (WJ-MSCs) not only possess the ability to differentiation into osteoblasts, but also produce a crucial secretory factor (vascular endothelial growth factor) to promote angiogenesis. Thus, Wharton’s jelly mesenchymal stem cell is expected to exert more vital role in improving diabetic bone regeneration. |
Publish Date |
2024-08-26 05:32 |
Citation |
<p>Zheng S, Hu GY, Li JH, Li YK. Potential plausible role of Wharton’s jelly mesenchymal stem cells for diabetic bone regeneration. <i>World J Stem Cells</i> 2024; 16(8): 824-826</p> |
URL |
https://www.wjgnet.com/1948-0210/full/v16/i8/824.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v16.i8.824 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345